Cell And Gene Therapy: Transforming Concept Into Reality

Regardless of the scale of your research or the specific workflows employed in your laboratory, advancing cell and gene therapy discovery and manufacturing often presents significant challenges, particularly when it comes to maintaining consistency and ensuring high-quality outcomes. PHC Corporation of North America (PHCNA) is committed to supporting researchers in overcoming these obstacles by providing innovative, precision-engineered instruments tailored to the evolving needs of modern laboratories. Our state-of-the-art solutions are specifically designed to enable continuous monitoring of glucose and lactate concentrations in cultured cells, which offers real-time insights that are critical for optimizing experimental conditions. Additionally, our technologies facilitate robust quantitative analysis of cells grown in both two-dimensional (2D) and three-dimensional (3D) environments to empower researchers to generate more reliable data and accelerate the pace of discovery in regenerative medicine and therapeutic development.

Access the full brochure to learn more.